SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of contract liabilities

	2022		2021
Customer deposits for commercial products	$	493	$	508
Total contract liabilities	$	493	$	508

Summary of changes in contract liabilities

Balance at December 31, 2020	$	994
Additions		435
Customer deposits returned		(713	)
Transfers to Revenue		(208	)
Balance at December 31, 2021		508
Transfers to Revenue		(15	)
Balance at March 31, 2022	$	493

Summary of fair value measurements of assets and liabilities

	Total		Level 1		Level 2		Level 3
Fair value of contingent stock consideration	$	584	$	-	$	-	$	584
Fair value of Series A Note	$	3,095	$	-	$	-	$	3,095
Fair value of Series B Note	$	6,451	$	-	$	-	$	6,451

	Total		Level 1		Level 2		Level 3
Fair value of contingent stock consideration	$	1,430	$	-	$	-	$	1,430
Fair value of Series A Note	$	3,075	$	-	$	-	$	3,075
Fair value of Series B Note	$	6,857	$	-	$	-	$	6,857

Schedule of asets and liabilities measured at fair value

Fair value at December 31, 2021	$	9,932
Change in fair value of Series A Note		20
Change in fair value of Series B Note		260
Conversion of Series B Note		(666	)
Fair value of Series A and B Notes at March 31, 2022	$	9,546

Schedule of financial instruments

Date of valuation	March 31, 2022			December 31,  2021
Stock price	$	0.26		$	0.36
Conversion price	$	1.32		$	1.32
Term (in years) – Series A Note		0.58			0.83
Term (in years) – Series B Note		0			0.13
Volatility – Series A Note		75	%		85	%
Volatility – Series B Note		75	%		65	%
Risk-free interest rate – Series A Note		1.15	%		0.32	%
Risk-free interest rate – Series B Note		1.15	%		0.06	%
Interest rate		18	%		18	%

Schedule of basic and diluted loss per share

	For the Three Months Ended
	March 31, 2022			March 31, 2021
Net income (loss) attributable to the Company	$	(5,151	)	$	(3,171	)
Weighted average outstanding shares of common stock		68,849,400			47,686,793
Dilutive potential common stock shares from:
Vested Stock options from the Company’s 2017 Equity Incentive Plan		-			-
Warrants		-			-
Conversion of convertible notes		-			-
Issuance of contingent shares relating to CHI acquisition		-			-
Common stock and common stock equivalents		68,849,400			47,686,793
Income (loss) per share:
Basic net income (loss) per share	$	(0.07	)	$	(0.07	)
Diluted net income (loss) per share	$	(0.07	)	$	(0.07	)

Schedule of diluted net income (loss)

	Three months ended March 31,
	2022		2021
Vested stock options from the Company’s 2017 Equity Incentive Plan		3,760,015		3,002,525
Warrants		615,530		2,479,849
Shares to be issued upon conversion of convertible payable		115,047		115,047
Total		4,490,592		5,597,421